Comments

Cytek Biosciences Stock Guidance

CTKBNASDAQ
Logo brought to you by Benzinga Data
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$4.30
-0.19-4.23%
At close: -
$4.30
0.000.00%
After Hours: 4:00 PM EDT
Q4 2024 Earnings were released on Thu Feb 27th, after the market close
The most recent conference call was at 16:30 PM, 4 days ago Click to view past webcast
Cytek Biosciences (CTKB) ForecastNewsEarningsCytek Biosciences (CTKB) Options

Guidance

DividendsAnalyst RatingsInsider TradesShort Interest

Cytek Biosciences Stock Guidance | NASDAQ:CTKB | Benzinga

Cytek Biosciences issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.

Data brought to you by Benzinga APIs

FAQ

Q

What is the most recent guidance for Cytek Biosciences (CTKB)?

A

There have been no specific sales or earnings guidance reported for Cytek Biosciences in recent months.

Browse guidance and forecast on all stocks.

People Also Watch

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2025 Benzinga | All Rights Reserved